These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 27104502

  • 1. Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
    Sovago I, Wang W, Qiu D, Raijada D, Rantanen J, Grohganz H, Rades T, Bond AD, Löbmann K.
    Molecules; 2016 Apr 19; 21(4):509. PubMed ID: 27104502
    [Abstract] [Full Text] [Related]

  • 2. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, Rades T, Löbmann K.
    J Pharm Pharmacol; 2016 May 19; 68(5):615-24. PubMed ID: 26245703
    [Abstract] [Full Text] [Related]

  • 3. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A, Grohganz H, Löbmann K, Rades T, Leopold CS.
    Eur J Pharm Biopharm; 2016 Dec 19; 109():140-148. PubMed ID: 27746228
    [Abstract] [Full Text] [Related]

  • 4. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW, Löbmann K, Grohganz H, Rades T, Chieng N.
    J Pharm Pharmacol; 2016 Jan 19; 68(1):36-45. PubMed ID: 26663364
    [Abstract] [Full Text] [Related]

  • 5. Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
    Beyer A, Grohganz H, Löbmann K, Rades T, Leopold CS.
    Int J Pharm; 2017 Jun 30; 526(1-2):88-94. PubMed ID: 28392278
    [Abstract] [Full Text] [Related]

  • 6. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N, Aaltonen J, Saville D, Rades T.
    Eur J Pharm Biopharm; 2009 Jan 30; 71(1):47-54. PubMed ID: 18644443
    [Abstract] [Full Text] [Related]

  • 7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 8. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A, Radi L, Grohganz H, Löbmann K, Rades T, Leopold CS.
    Eur J Pharm Biopharm; 2016 Jul 30; 104():72-81. PubMed ID: 27130786
    [Abstract] [Full Text] [Related]

  • 9. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A, Cao T, Lubach J, Listro T, Acquarulo L, Zhang F.
    Eur J Pharm Sci; 2017 May 01; 102():115-125. PubMed ID: 28259831
    [Abstract] [Full Text] [Related]

  • 10. [The development of co-amorphous drug systems].
    Yao J, Shi NQ, Wang XL.
    Yao Xue Xue Bao; 2013 May 01; 48(5):648-54. PubMed ID: 23888685
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G, Lobo L, Dengale S, Grohganz H, Rades T, Löbmann K.
    Eur J Pharm Biopharm; 2018 Nov 01; 132():192-199. PubMed ID: 30266670
    [Abstract] [Full Text] [Related]

  • 12. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt B):942-51. PubMed ID: 24075980
    [Abstract] [Full Text] [Related]

  • 13. Formation of physically stable amorphous drugs by milling with Neusilin.
    Gupta MK, Vanwert A, Bogner RH.
    J Pharm Sci; 2003 Mar 01; 92(3):536-51. PubMed ID: 12587115
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T.
    Mol Pharm; 2011 Oct 03; 8(5):1919-28. PubMed ID: 21815614
    [Abstract] [Full Text] [Related]

  • 17. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
    Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H.
    Drug Dev Ind Pharm; 2017 Feb 03; 43(2):283-292. PubMed ID: 27648489
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.
    Beyer A, Grohganz H, Löbmann K, Rades T, Leopold CS.
    Molecules; 2015 Oct 27; 20(10):19571-87. PubMed ID: 26516832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.